title: A stronger role for science.
abstract: Drug development is inherently risky, but if perceived short-term business imperatives outweigh sound science in decision-making, the magnitude of these risks might become unsustainable.
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects; D017326:Clinical Trials, Phase III as Topic; D003657:Decision Making; D055808:Drug Discovery / Q000191:economics / Q000639:trends*; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D006801:Humans; D011804:Quinolines / Q000009:adverse effects; D012106:Research
chemical_list: D000924:Anticholesteremic Agents; D011804:Quinolines; C483909:torcetrapib